Showing results (1321-1330 of 1,400) with videos related to

Sort By:
Pageof 140
JCO Precision Oncology|December 23, 2024
Optimizing Mainstreaming of Genetic Testing in Parallel With Ovarian and Endometrial Cancer Tumor Testing: How Do We Maximize Our Impact?Ying L Liu, Tiffany Y Sia, Nancy Varice, et al.
JCO Precision Oncology|December 23, 2024
Targeted-Agent Continual Reassessment Method: A Novel Bayesian Enrichment Design for Phase I Trials of Molecularly Targeted TherapiesClement Ma, David S Shulman, Hasan Al-Sayegh, et al.
JCO Precision Oncology|January 17, 2025
Artificial Intelligence-Powered Human Epidermal Growth Factor Receptor 2 and Tumor Microenvironment Analysis in Human Epidermal Growth Factor Receptor 2-Amplified Metastatic Colorectal Cancer: Exploratory Analysis of Phase II TRIUMPH TrialMitsuho Imai, Yoshiaki Nakamura, Sangwon Shin, et al.
JCO Precision Oncology|February 6, 2025
Improving Individualized Rhabdomyosarcoma Prognosis Predictions Using Somatic Molecular BiomarkersMark Zobeck, Javed Khan, Rajkumar Venkatramani, et al.
JCO Precision Oncology|February 6, 2025
Phase II Study of Copanlisib in Patients With PTEN Loss: Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols Z1G and Z1HMohamed A Gouda, Zihan Wei, Jordi Rodon, et al.
JCO Precision Oncology|December 12, 2024
Clinical Utility of a Circulating Tumor Cell-Based Cerebrospinal Fluid Assay in the Diagnosis and Molecular Analysis of Leptomeningeal Disease in Patients With Advanced Non-Small Cell Lung CancerJyoti Malhotra, Ramya Muddasani, Jeremy Fricke, et al.
JCO Precision Oncology|December 12, 2024
Phase II Study of Sunitinib in Tumors With c-KIT Mutations: Results From the NCI MATCH ECOG-ACRIN Trial (EAY131) Subprotocol VLilian T Gien, Zihe Song, Andrew Poklepovic, et al.
JCO Precision Oncology|December 5, 2024
Genomic Landscape of Malignant Phyllodes Tumors Identifies Subsets for Targeted TherapyRani Bansal, Tolulope Adeyelu, Andrew Elliott, et al.
JCO Precision Oncology|December 6, 2024
KRAS Variants Are Associated With Survival Outcomes and Genomic Alterations in Biliary Tract CancersRebecca Gelfer, Aiste Gulla, Hannah L Kalvin, et al.
JCO Precision Oncology|December 6, 2024
Cancer-Control Outcomes of Patients With Metastatic Castration-Resistant Prostate Cancer With BRCA Gene or Tumor Suppressor Mutations Undergoing 177-Lutetium Prostate-Specific Membrane Antigen Radioligand TherapyMike Wenzel, Florestan Koll, Benedikt Hoeh, et al.
Pageof 140